IDiyas

For the Inventor, By the Inventor

Utrecht, Netherlands

Geert Jan Sterk

USPTO Granted Patents = 28

 

Average Co-Inventor Count = 2.2

ph-index = 9

Forward Citations = 165(Granted Patents)


Location History:

  • RN Utrecht, NL (1991)
  • Utrecht, DE (2004)
  • JJ Utecht, NL (2005)
  • Stadhouderslaan, NL (2007)
  • Utecht, NL (2006 - 2009)
  • JJ Utrecht, NL (2009 - 2015)
  • Utrecht, NL (1991 - 2016)
  • Constance, DE (2016)

Company Filing History:

goldMedal9 out of 84 
 
Altana Pharma Ag
 patents
silverMedal4 out of 5 
 
Cedona Pharmaceuticals B.v.
 patents
bronzeMedal4 out of 63 
 
Nycomed Gmbh
 patents
4. 4 out of 47 
 
Takeda Gmbh
 patents
5. 3 out of 136 
 
Byk Gulden Lomberg Chemische Fabrik Gmbh
 patents
6. 1 out of 1 
 
Khondiron IP B.v.
 patent
7. 1 out of 1 
 
Altana Pharma B.v.
 patent
8. 1 out of 2 
 
Byk Nederland Bv
 patents
9. 1 out of 1 
 
Rephartox
 patent

Years Active: 1991-2016

Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents
1. 9388156 - Chromanyl derivatives for treating mitochondrial disease (2016-07-12),
2. 9340522 - Pyrazolone-derivatives and their use as PDE-4 inhibitors (2016-05-17),
3. 9090597 - Pyrazolone derivatives as PDE4 inhibitors (2015-07-28),
4. 8865745 - Pyrazolone derivatives as PDE4 inhibitors (2014-10-21),
5. 8609848 - Pyrazolone-derivatives and their use as PDE-4 inhibitors (2013-12-17),
6. 8304436 - Pyrazolone derivatives as PDE4 inhibitors (2012-11-06),
7. 7820669 - 2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors (2010-10-26),
8. 7531540 - Phthalazinone-piperidino-derivatives as PDE4 inhibitors (2009-05-12),
9. 7494990 - 2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors (2009-02-24),
10. 7220746 - Pyrrolidinedione substituted piperidine-phthalazones as PDE4 inhibitors (2007-05-22),
11. 7186710 - Phthalazinones (2007-03-06),
12. 7179810 - Phthalazinone-piperidino-derivatives as PDE4 inhibitors (2007-02-20),
13. 7022696 - Piperazino-derivatives and their use as PDE4 inhibitor (2006-04-04),
14. 6953853 - Phthalazinone-piperidino-derivatives as PDE4 inhibitors (2005-10-11),
15. 6933296 - Compounds effective as β2-adrenoreceptor agonists as well as PDE4-inhibitors (2005-08-23),

Title: Unveiling the Innovative Mind of Geert Jan Sterk

Introduction:

Geert Jan Sterk, a visionary inventor hailing from Utrecht, NL, has made significant strides in the field of pharmaceuticals with his groundbreaking patents and inventions.

Latest Patents:

Among his impressive portfolio of 28 patents, Geert Jan Sterk's recent innovations include Chromanyl derivatives for treating mitochondrial disease, offering novel compounds that revolutionize the modulation of mitochondrial morphology and expression of key enzymes for ROS regulation. Additionally, his Pyrazolone-derivatives serve as potent PDE-4 inhibitors, showcasing his expertise in developing effective pharmaceutical solutions.

Career Highlights:

Having contributed his expertise to esteemed companies such as Altana Pharma AG and Cedona Pharmaceuticals B.V., Geert Jan Sterk has proven himself as a valuable asset in the pharmaceutical industry. His innovative approach and dedication to scientific advancement have earned him recognition among his peers and the scientific community.

Collaborations:

Throughout his career, Geert Jan Sterk has collaborated closely with notable professionals in the field, including the likes of Beate Schmidt and Armin Hatzelmann. These collaborations have led to synergistic efforts in research and development, resulting in cutting-edge solutions for complex medical challenges.

Conclusion:

In conclusion, Geert Jan Sterk's ingenuity and commitment to pushing the boundaries of pharmaceutical innovation have established him as a leading figure in the field. His patents and inventions not only reflect his passion for scientific discovery but also highlight his profound impact on the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…